Bookmark and Share
CHEMBL1958348 (CID 56924661) - Compound BioActivity Data
.
BioActivity Outcomes:
Active(2)
 
 
Unspecified(6)
 
 
Top Targets:
prostaglandin..(4)
 
 
 
BioAssay Types:
Literature(8)
 
 
 
BioActivity Types:
IC50(2)
 
 
Data download

Chemical Probe    Active    Inactive    Inconclusive    Unspecified   

Total Bioassays: 8    Data Row: 8   Total Pages: 1   
Sort: [Click the result table header to sort]
#SubstanceActivityBioAssayTargetLinks
OutcomeTypeValue [μM]
1
[SID136927755]
IC50 0.03Inhibition of ovine COX1 [AID648861, Type: Literature]Prostaglandin G/H synthase 1 [gi:548481]
View
2
[SID136927755]
IC50 0.38Inhibition of human recombinant COX2 [AID648862, Type: Literature]Prostaglandin G/H synthase 2 [gi:3915797]
View
3
[SID136927755]
Ratio of aspirin IC50 to compound IC50 for human recombinant COX2 [AID648864, Type: Literature]Prostaglandin G/H synthase 2 [gi:3915797]
View
4
[SID136927755]
Ratio of aspirin IC50 to compound IC50 for ovine COX1 [AID648863, Type: Literature]Prostaglandin G/H synthase 1 [gi:548481]
View
5
[SID136927755]
Antiinflammatory activity in rat assessed as inhibition of carrageenan-induced paw edema at 0.71 mmol/kg, po after 3 hrs relative to control [AID648865, Type: Literature]
View
6
[SID136927755]
Lipophilicity, log P of the compound [AID648869, Type: Literature]
View
7
[SID136927755]
Ulcerogenic effect in rat assessed as gastric ulcer overall length at 1.4 mmol/kg, po administered for 6 hrs [AID648871, Type: Literature]
View
8
[SID136927755]
Selectivity ratio of IC50 for ovine COX1 to IC50 for human recombinant COX2 [AID648873, Type: Literature]
View